Day One Biopharmaceuticals Inc. (DAWN) NASDAQ
$14.85 0.24 (1.64%)
Market Cap: $1.28B
As of 04/17/24 04:00 PM EDT. Market closed.
Day One Biopharmaceuticals Inc. (DAWN)
NASDAQ
$14.85
0.24 (1.64%)
Market Cap: $1.28B
As of 04/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
day one biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. we are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. our distinctive approach, together with ... read more
day one biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. we are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unparalleled ability to advance promising discoveries for patients of any age. we are ready to pursue the full potential of our therapies to improve the greatest number of lives as quickly as possible. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jeremy Bender
Full Time Employees
120
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jeremy Bender
Full Time Employees
120
Address
395 Oyster Point Boulevard, Suite 217, CA, San Francisco, 94080.
PRICE CHART FOR DAY ONE BIOPHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.02
Previous Close
$14.61
Days Range
$13.82 - $14.73
52 week range
$9.67 - $17.85
Volume
807,109
Avg. Volume (30 days)
757,955
Market Cap
$1.28B
Dividend Yield
-
P/E
-
Shares Outstanding
87,377,163
Open
$15.02
Previous Close
$14.61
Days Range
$13.82 - $14.73
52 week range
$9.67 - $17.85
Volume
807,109
Avg. Volume (30 days)
757,955
Market Cap
$1.28B
Dividend Yield
-
P/E
-
Shares Outstanding
87,377,163
FINANCIAL STATEMENTS FOR DAY ONE BIOPHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR DAY ONE BIOPHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Blackman Samuel C. | HEAD OF R&D | Mar 25, 2024 | Sale | $16.01 | 10,000 | 160,055 | 1,184,662 | Mar 26, 2024, 06:09 PM |
| Blackman Samuel C. | HEAD OF R&D | Mar 11, 2024 | Sale | $15.24 | 30,000 | 457,314 | 1,194,662 | Mar 13, 2024, 04:24 PM |
| Blackman Samuel C. | HEAD OF R&D | Feb 27, 2024 | Sale | $16.11 | 20,000 | 322,166 | 1,224,662 | Feb 28, 2024, 07:55 PM |
| Dubow Adam | GENERAL COUNSEL | Feb 16, 2024 | Sale | $15.25 | 3,242 | 49,434 | 16,585 | Feb 20, 2024, 06:48 PM |
| York Charles N II | COO, CFO AND SECRETARY | Feb 16, 2024 | Sale | $15.25 | 2,666 | 40,651 | 277,754 | Feb 20, 2024, 06:36 PM |
| Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | Feb 16, 2024 | Sale | $15.25 | 2,258 | 34,430 | 1,244,662 | Feb 20, 2024, 06:26 PM |
| Bender Jeremy | CHIEF EXECUTIVE OFFICER | Feb 16, 2024 | Sale | $15.25 | 7,615 | 116,114 | 721,813 | Feb 20, 2024, 06:14 PM |
| York Charles N II | COO, CFO and Secretary | Nov 16, 2023 | Sale | $11.69 | 956 | 11,176 | 270,170 | Nov 17, 2023, 06:33 PM |
| Dubow Adam | General Counsel | Nov 16, 2023 | Sale | $11.69 | 5,313 | 62,109 | 11,428 | Nov 17, 2023, 06:30 PM |
| Blackman Samuel C. | Head of Research and Developme | Nov 16, 2023 | Sale | $11.69 | 709 | 8,288 | 1,238,234 | Nov 17, 2023, 06:26 PM |
| Bender Jeremy | Chief Executive Officer | Nov 16, 2023 | Sale | $11.69 | 3,107 | 36,321 | 709,429 | Nov 17, 2023, 06:20 PM |
| AI Day1 LLC | 10% Owner | Oct 20, 2023 | Buy | $9.97 | 111,387 | 1,110,907 | 12,929,322 | Oct 20, 2023, 04:02 PM |
| AI Day1 LLC | 10% Owner | Oct 19, 2023 | Buy | $10.06 | 384,400 | 3,867,371 | 12,817,935 | Oct 20, 2023, 04:02 PM |
| AI Day1 LLC | 10% Owner | Oct 18, 2023 | Buy | $10.21 | 979,667 | 10,000,049 | 12,433,535 | Oct 20, 2023, 04:02 PM |
| York Charles N II | COO, CFO and Secretary | Aug 17, 2023 | Sale | $13.86 | 922 | 12,779 | 267,501 | Aug 17, 2023, 07:02 PM |
| Blackman Samuel C. | Head of Research and Developme | Aug 17, 2023 | Sale | $13.86 | 668 | 9,258 | 1,236,319 | Aug 17, 2023, 06:21 PM |
| Bender Jeremy | Chief Executive Officer | Aug 17, 2023 | Sale | $13.86 | 2,996 | 41,525 | 704,224 | Aug 17, 2023, 06:16 PM |
| AI Day1 LLC | 10% Owner | Jun 09, 2023 | Buy | $13.00 | 769,230 | 9,999,990 | 11,453,868 | Jun 12, 2023, 04:03 PM |
| Blackman Samuel C. | Chief Medical Officer | Jun 05, 2023 | Sale | $16.00 | 1,229 | 19,664 | 1,234,363 | Jun 07, 2023, 04:51 PM |
| York Charles N II | COO, CFO and Secretary | May 16, 2023 | Sale | $13.12 | 955 | 12,532 | 264,798 | May 17, 2023, 06:36 PM |
| Blackman Samuel C. | Chief Medical Officer | May 16, 2023 | Sale | $13.12 | 692 | 9,081 | 1,235,592 | May 17, 2023, 06:31 PM |
| Bender Jeremy | Chief Executive Officer | May 16, 2023 | Sale | $13.12 | 3,104 | 40,732 | 1,179,484 | May 17, 2023, 06:27 PM |
| Blackman Samuel C. | Chief Medical Officer | Mar 10, 2023 | Sale | $18.05 | 10,000 | 180,484 | 1,233,660 | Mar 14, 2023, 06:19 PM |
| Bender Jeremy | Chief Executive Officer | Mar 07, 2023 | Sale | $20.01 | 12,500 | 250,114 | 1,174,276 | Mar 08, 2023, 05:50 PM |
| Grant Julie Papanek | Director | Mar 01, 2023 | Sale | $18.61 | 25,000 | 465,303 | 330,000 | Mar 03, 2023, 05:48 PM |
| York Charles N II | COO, CFO and Secretary | Feb 17, 2023 | Sale | $20.03 | 9,377 | 187,790 | 262,128 | Feb 21, 2023, 05:01 PM |
| York Charles N II | COO, CFO and Secretary | Feb 16, 2023 | Sale | $19.57 | 930 | 18,203 | 271,505 | Feb 17, 2023, 05:35 PM |
| Blackman Samuel C. | Chief Medical Officer | Feb 16, 2023 | Sale | $19.57 | 674 | 13,192 | 1,243,660 | Feb 17, 2023, 05:30 PM |
| Bender Jeremy | Chief Executive Officer | Feb 16, 2023 | Sale | $19.57 | 3,022 | 59,150 | 1,186,776 | Feb 17, 2023, 05:26 PM |
| Blackman Samuel C. | Chief Medical Officer | Feb 10, 2023 | Sale | $20.07 | 10,000 | 200,659 | 1,241,710 | Feb 13, 2023, 06:28 PM |
| Grant Julie Papanek | Director | Feb 01, 2023 | Sale | $21.23 | 25,000 | 530,794 | 356,106 | Feb 03, 2023, 04:48 PM |
| Bender Jeremy | Chief Executive Officer | Jan 23, 2023 | Sale | $22.00 | 12,500 | 274,988 | 1,181,486 | Jan 24, 2023, 05:11 PM |
| York Charles N II | COO, CFO and Secretary | Jan 20, 2023 | Sale | $22.75 | 10,000 | 227,523 | 268,810 | Jan 23, 2023, 06:00 PM |
| Blackman Samuel C. | Chief Medical Officer | Jan 10, 2023 | Sale | $22.86 | 10,000 | 228,644 | 1,252,648 | Jan 11, 2023, 05:09 PM |
| Grant Julie Papanek | Director | Jan 03, 2023 | Sale | $20.65 | 25,000 | 516,147 | 387,610 | Jan 04, 2023, 05:51 PM |
| Bender Jeremy | Chief Executive Officer | Dec 21, 2022 | Sale | $20.32 | 12,500 | 253,969 | 1,192,424 | Dec 22, 2022, 05:50 PM |
| York Charles N II | COO, CFO and Secretary | Dec 20, 2022 | Sale | $20.07 | 10,000 | 200,650 | 276,497 | Dec 22, 2022, 05:43 PM |
| Grant Julie Papanek | Director | Dec 08, 2022 | Sale | $22.08 | 4,358 | 96,210 | 405,000 | Dec 12, 2022, 04:56 PM |
| Grant Julie Papanek | Director | Dec 02, 2022 | Sale | $21.55 | 5,000 | 107,726 | 409,358 | Dec 05, 2022, 04:57 PM |
| Grant Julie Papanek | Director | Dec 01, 2022 | Sale | $21.75 | 5,000 | 108,754 | 414,598 | Dec 05, 2022, 04:57 PM |
| Blackman Samuel C. | Chief Medical Officer | Dec 01, 2022 | Sale | $21.45 | 10,000 | 214,530 | 1,261,048 | Dec 05, 2022, 04:43 PM |
| York Charles N II | COO, CFO and Secretary | Nov 21, 2022 | Sale | $20.76 | 10,000 | 207,570 | 286,797 | Nov 22, 2022, 06:46 PM |
| Bender Jeremy | Chief Executive Officer | Nov 21, 2022 | Sale | $20.76 | 12,500 | 259,479 | 1,205,324 | Nov 22, 2022, 06:43 PM |
| York Charles N II | COO, CFO and Secretary | Nov 16, 2022 | Sale | $21.46 | 430 | 9,228 | 296,497 | Nov 17, 2022, 05:49 PM |
| Blackman Samuel C. | Chief Medical Officer | Nov 16, 2022 | Sale | $21.46 | 377 | 8,090 | 1,270,148 | Nov 17, 2022, 05:41 PM |
| Bender Jeremy | Chief Executive Officer | Nov 16, 2022 | Sale | $21.46 | 1,513 | 32,469 | 1,217,424 | Nov 17, 2022, 05:33 PM |
| York Charles N II | COO, CFO and Secretary | Nov 01, 2022 | Sale | $20.03 | 10,000 | 200,313 | 294,401 | Nov 03, 2022, 05:49 PM |
| Grant Julie Papanek | Director | Nov 01, 2022 | Sale | $20.04 | 5,000 | 100,209 | 424,358 | Nov 03, 2022, 05:44 PM |
| Grant Julie Papanek | Director | Nov 02, 2022 | Sale | $20.01 | 5,000 | 100,069 | 419,358 | Nov 03, 2022, 05:44 PM |
| Blackman Samuel C. | Chief Medical Officer | Nov 01, 2022 | Sale | $20.00 | 10,000 | 200,050 | 1,269,338 | Nov 03, 2022, 05:36 PM |
| Bender Jeremy | Chief Executive Officer | Nov 01, 2022 | Sale | $20.03 | 12,500 | 250,355 | 1,215,375 | Nov 03, 2022, 05:30 PM |
| York Charles N II | COO, CFO and Secretary | Oct 03, 2022 | Sale | $20.05 | 10,000 | 200,473 | 304,401 | Oct 05, 2022, 04:36 PM |
| Grant Julie Papanek | Director | Oct 04, 2022 | Sale | $20.00 | 5,000 | 100,000 | 429,358 | Oct 05, 2022, 04:32 PM |
| Grant Julie Papanek | Director | Oct 03, 2022 | Sale | $20.06 | 5,000 | 100,315 | 434,358 | Oct 05, 2022, 04:32 PM |
| Blackman Samuel C. | Chief Medical Officer | Oct 03, 2022 | Sale | $19.99 | 10,000 | 199,852 | 1,279,338 | Oct 05, 2022, 04:25 PM |
| Bender Jeremy | Chief Executive Officer | Oct 03, 2022 | Sale | $20.05 | 12,500 | 250,646 | 1,227,875 | Oct 05, 2022, 04:22 PM |
| Canaan XI L.P. | 10% Owner | Sep 21, 2022 | Sale | $18.55 | 613,603 | 11,380,780 | 8,470,407 | Sep 22, 2022, 04:00 PM |
| Grant Julie Papanek | Director | Sep 21, 2022 | Sale | $18.55 | 613,603 | 11,380,780 | 8,470,407 | Sep 22, 2022, 04:00 PM |
| Grant Julie Papanek | Director | Sep 20, 2022 | Sale | $19.51 | 148,670 | 2,900,425 | 9,080,170 | Sep 20, 2022, 06:05 PM |
| Grant Julie Papanek | Director | Sep 19, 2022 | Sale | $20.57 | 76,725 | 1,578,233 | 9,226,574 | Sep 20, 2022, 06:05 PM |
| Grant Julie Papanek | Director | Sep 16, 2022 | Sale | $21.55 | 115,307 | 2,484,458 | 9,307,021 | Sep 20, 2022, 06:05 PM |
| Canaan XI L.P. | 10% Owner | Sep 20, 2022 | Sale | $19.51 | 148,670 | 2,900,425 | 9,080,170 | Sep 20, 2022, 05:47 PM |
| Canaan XI L.P. | 10% Owner | Sep 19, 2022 | Sale | $20.57 | 76,725 | 1,578,233 | 9,226,574 | Sep 20, 2022, 05:47 PM |
| Canaan XI L.P. | 10% Owner | Sep 16, 2022 | Sale | $21.55 | 115,307 | 2,484,458 | 9,307,021 | Sep 20, 2022, 05:47 PM |
| Grant Julie Papanek | Director | Sep 15, 2022 | Sale | $22.85 | 51,281 | 1,171,809 | 9,421,920 | Sep 15, 2022, 07:53 PM |
| Grant Julie Papanek | Director | Sep 14, 2022 | Sale | $23.68 | 106,111 | 2,512,943 | 9,470,271 | Sep 15, 2022, 07:53 PM |
| Grant Julie Papanek | Director | Sep 13, 2022 | Sale | $24.40 | 87,647 | 2,138,332 | 9,577,001 | Sep 15, 2022, 07:53 PM |
| Canaan XI L.P. | 10% Owner | Sep 14, 2022 | Sale | $23.68 | 106,111 | 2,512,943 | 9,470,271 | Sep 15, 2022, 07:48 PM |
| Canaan XI L.P. | 10% Owner | Sep 13, 2022 | Sale | $24.40 | 87,647 | 2,138,332 | 9,577,001 | Sep 15, 2022, 07:48 PM |
| Canaan XI L.P. | 10% Owner | Sep 15, 2022 | Sale | $22.85 | 51,281 | 1,171,809 | 9,421,920 | Sep 15, 2022, 07:48 PM |
| Grant Papanek Julie | Director | Sep 02, 2022 | Sale | $23.82 | 5,000 | 119,108 | 439,358 | Sep 15, 2022, 01:21 PM |
| York Charles N II | COO, CFO and Secretary | Sep 01, 2022 | Sale | $23.25 | 10,000 | 232,484 | 315,795 | Sep 06, 2022, 07:54 PM |
| Grant Papanek Julie | Director | Sep 01, 2022 | Sale | $23.27 | 5,000 | 116,358 | 444,889 | Sep 06, 2022, 07:52 PM |
| Blackman Samuel C. | Chief Medical Officer | Sep 01, 2022 | Sale | $23.25 | 10,000 | 232,452 | 1,290,927 | Sep 06, 2022, 07:51 PM |
| Bender Jeremy | Chief Executive Officer | Sep 01, 2022 | Sale | $23.25 | 12,500 | 290,581 | 1,242,234 | Sep 06, 2022, 07:50 PM |
| Bender Jeremy | Chief Executive Officer | Sep 01, 2022 | Sale | $23.25 | 12,500 | 290,581 | 1,242,234 | Sep 06, 2022, 07:49 PM |
| Blackman Samuel C. | Chief Medical Officer | Aug 16, 2022 | Sale | $24.31 | 941 | 22,876 | 1,299,338 | Aug 17, 2022, 07:25 PM |
| Bender Jeremy | Chief Executive Officer | Aug 16, 2022 | Sale | $24.31 | 4,003 | 97,313 | 1,252,875 | Aug 17, 2022, 07:24 PM |
| York Charles N II | COO, CFO and Secretary | Aug 16, 2022 | Sale | $24.31 | 1,089 | 26,474 | 324,401 | Aug 17, 2022, 07:23 PM |
| Grant Papanek Julie | Director | Aug 05, 2022 | Sale | $20.00 | 5,000 | 100,000 | 449,358 | Aug 08, 2022, 08:03 PM |
| Grant Papanek Julie | Director | Aug 04, 2022 | Sale | $20.00 | 5,000 | 100,004 | 454,358 | Aug 08, 2022, 08:03 PM |
| York Charles N II | COO, CFO and Secretary | Aug 04, 2022 | Sale | $20.05 | 10,000 | 200,541 | 321,365 | Aug 05, 2022, 05:20 PM |
| Bender Jeremy | Chief Executive Officer | Aug 04, 2022 | Sale | $20.00 | 12,500 | 250,021 | 1,246,192 | Aug 05, 2022, 05:19 PM |
| Blackman Samuel C. | Chief Medical Officer | Aug 01, 2022 | Sale | $16.88 | 10,000 | 168,810 | 1,296,718 | Aug 03, 2022, 06:57 PM |
| York Charles N II | COO, CFO and Secretary | Jul 18, 2022 | Sale | $20.00 | 2,500 | 50,000 | 331,365 | Jul 20, 2022, 06:18 PM |
| Grant Papanek Julie | Director | Jul 18, 2022 | Sale | $20.00 | 2,600 | 52,001 | 459,358 | Jul 20, 2022, 06:17 PM |
| Bender Jeremy | Chief Executive Officer | Jul 18, 2022 | Sale | $20.00 | 2,600 | 52,003 | 1,258,692 | Jul 20, 2022, 06:17 PM |
| Grant Papanek Julie | Director | Jul 05, 2022 | Sale | $20.00 | 800 | 16,000 | 463,200 | Jul 12, 2022, 09:14 PM |
| Grant Papanek Julie | Director | Jul 01, 2022 | Sale | $20.00 | 1,000 | 20,000 | 464,000 | Jul 12, 2022, 09:14 PM |
| Grant Papanek Julie | Director | Jul 08, 2022 | Sale | $20.00 | 1,242 | 24,840 | 461,958 | Jul 12, 2022, 07:52 PM |
| York Charles N II | COO, CFO and Secretary | Jul 08, 2022 | Sale | $20.00 | 1,416 | 28,320 | 333,865 | Jul 12, 2022, 07:31 PM |
| Bender Jeremy | Chief Executive Officer | Jul 08, 2022 | Sale | $20.00 | 1,795 | 35,900 | 1,261,292 | Jul 12, 2022, 07:30 PM |
| York Charles N II | COO, CFO and Secretary | Jul 01, 2022 | Sale | $20.00 | 1,479 | 29,580 | 336,081 | Jul 06, 2022, 09:00 PM |
| York Charles N II | COO, CFO and Secretary | Jul 05, 2022 | Sale | $20.00 | 800 | 16,000 | 335,281 | Jul 06, 2022, 09:00 PM |
| Grant Papanek Julie | Director | Jul 05, 2022 | Sale | $20.00 | 800 | 16,000 | 463,200 | Jul 06, 2022, 08:58 PM |
| Grant Papanek Julie | Director | Jul 01, 2022 | Sale | $20.00 | 1,000 | 20,000 | 464,000 | Jul 06, 2022, 08:58 PM |
| Blackman Samuel C. | Chief Medical Officer | Jul 01, 2022 | Sale | $18.72 | 10,000 | 187,158 | 1,310,894 | Jul 06, 2022, 08:57 PM |
| Bender Jeremy | Chief Executive Officer | Jul 05, 2022 | Sale | $20.00 | 857 | 17,140 | 1,263,087 | Jul 06, 2022, 08:56 PM |
| Bender Jeremy | Chief Executive Officer | Jul 01, 2022 | Sale | $20.00 | 1,746 | 34,920 | 1,263,944 | Jul 06, 2022, 08:56 PM |
| Atlas Venture Opportunity Fund II, L.P. | 10% Owner | Jun 17, 2022 | Buy | $15.00 | 766,667 | 11,500,005 | 766,667 | Jun 22, 2022, 05:09 PM |
| Gladstone Michael | Director | Jun 17, 2022 | Buy | $15.00 | 766,667 | 11,500,005 | 766,667 | Jun 22, 2022, 04:47 PM |
| AI Day1 LLC | 10% Owner | Jun 17, 2022 | Buy | $15.00 | 1,200,000 | 18,000,000 | 10,684,638 | Jun 21, 2022, 04:37 PM |
| Blackman Samuel C. | Chief Medical Officer | Jun 15, 2022 | Sale | $16.26 | 50,000 | 813,155 | 1,316,718 | Jun 17, 2022, 09:47 PM |
| AI Day1 LLC | 10% Owner | Jan 20, 2022 | Buy | $14.73 | 4,615 | 67,976 | 9,484,638 | Jan 20, 2022, 06:37 PM |
| AI Day1 LLC | 10% Owner | Jan 19, 2022 | Buy | $14.70 | 58,818 | 864,566 | 9,480,023 | Jan 20, 2022, 06:37 PM |
| AI Day1 LLC | 10% Owner | Jan 18, 2022 | Buy | $14.26 | 43,429 | 619,367 | 9,421,205 | Jan 20, 2022, 06:37 PM |
| Blackman Samuel C. | Chief Medical Officer | Jan 03, 2022 | Sale | $17.10 | 10,000 | 171,018 | 1,370,046 | Jan 05, 2022, 08:08 PM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Dec 08, 2021 | Sale | $18.03 | 110,338 | 1,989,394 | 6,120,124 | Dec 09, 2021, 06:04 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Dec 07, 2021 | Sale | $18.76 | 186,935 | 3,507,475 | 6,288,652 | Dec 09, 2021, 06:04 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Dec 06, 2021 | Sale | $18.05 | 97,692 | 1,763,341 | 6,417,397 | Dec 07, 2021, 06:01 AM |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Dec 03, 2021 | Sale | $18.47 | 12,517 | 231,189 | 6,515,089 | Dec 07, 2021, 06:01 AM |
| Blackman Samuel C. | Chief Medical Officer | Dec 01, 2021 | Sale | $17.22 | 10,000 | 172,242 | 1,381,629 | Dec 03, 2021, 07:19 PM |
| Grant Papanek Julie | Director | Jun 01, 2021 | Buy | $16.00 | 13,000 | 208,000 | 10,735,645 | Jun 02, 2021, 08:52 PM |
| Josey John A. | Director | Jun 01, 2021 | Buy | $16.00 | 7,000 | 112,000 | 72,292 | Jun 01, 2021, 09:51 PM |
| Becker Daniel J. | Director | Jun 01, 2021 | Buy | $16.00 | 5,000 | 80,000 | 5,000 | Jun 01, 2021, 09:50 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Blackman Samuel C. | HEAD OF R&D | 03/25/2024 | 160,055 |
| Blackman Samuel C. | HEAD OF R&D | 03/11/2024 | 457,314 |
| Blackman Samuel C. | HEAD OF R&D | 02/27/2024 | 322,166 |
| Dubow Adam | GENERAL COUNSEL | 02/16/2024 | 49,434 |
| York Charles N II | COO, CFO AND SECRETARY | 02/16/2024 | 40,651 |
| Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | 02/16/2024 | 34,430 |
| Bender Jeremy | CHIEF EXECUTIVE OFFICER | 02/16/2024 | 116,114 |
| York Charles N II | COO, CFO and Secretary | 11/16/2023 | 11,176 |
| Dubow Adam | General Counsel | 11/16/2023 | 62,109 |
| Blackman Samuel C. | Head of Research and Developme | 11/16/2023 | 8,288 |
| Bender Jeremy | Chief Executive Officer | 11/16/2023 | 36,321 |
| AI Day1 LLC | 10% Owner | 10/20/2023 | 1,110,907 |
| AI Day1 LLC | 10% Owner | 10/19/2023 | 3,867,371 |
| AI Day1 LLC | 10% Owner | 10/18/2023 | 10,000,049 |
| York Charles N II | COO, CFO and Secretary | 08/17/2023 | 12,779 |
| Blackman Samuel C. | Head of Research and Developme | 08/17/2023 | 9,258 |
| Bender Jeremy | Chief Executive Officer | 08/17/2023 | 41,525 |
| AI Day1 LLC | 10% Owner | 06/09/2023 | 9,999,990 |
| Blackman Samuel C. | Chief Medical Officer | 06/05/2023 | 19,664 |
| York Charles N II | COO, CFO and Secretary | 05/16/2023 | 12,532 |
| Blackman Samuel C. | Chief Medical Officer | 05/16/2023 | 9,081 |
| Bender Jeremy | Chief Executive Officer | 05/16/2023 | 40,732 |
| Blackman Samuel C. | Chief Medical Officer | 03/10/2023 | 180,484 |
| Bender Jeremy | Chief Executive Officer | 03/07/2023 | 250,114 |
| Grant Julie Papanek | Director | 03/01/2023 | 465,303 |
| York Charles N II | COO, CFO and Secretary | 02/17/2023 | 187,790 |
| York Charles N II | COO, CFO and Secretary | 02/16/2023 | 18,203 |
| Blackman Samuel C. | Chief Medical Officer | 02/16/2023 | 13,192 |
| Bender Jeremy | Chief Executive Officer | 02/16/2023 | 59,150 |
| Blackman Samuel C. | Chief Medical Officer | 02/10/2023 | 200,659 |
| Grant Julie Papanek | Director | 02/01/2023 | 530,794 |
| Bender Jeremy | Chief Executive Officer | 01/23/2023 | 274,988 |
| York Charles N II | COO, CFO and Secretary | 01/20/2023 | 227,523 |
| Blackman Samuel C. | Chief Medical Officer | 01/10/2023 | 228,644 |
| Grant Julie Papanek | Director | 01/03/2023 | 516,147 |
| Bender Jeremy | Chief Executive Officer | 12/21/2022 | 253,969 |
| York Charles N II | COO, CFO and Secretary | 12/20/2022 | 200,650 |
| Grant Julie Papanek | Director | 12/08/2022 | 96,210 |
| Grant Julie Papanek | Director | 12/02/2022 | 107,726 |
| Grant Julie Papanek | Director | 12/01/2022 | 108,754 |
| Blackman Samuel C. | Chief Medical Officer | 12/01/2022 | 214,530 |
| York Charles N II | COO, CFO and Secretary | 11/21/2022 | 207,570 |
| Bender Jeremy | Chief Executive Officer | 11/21/2022 | 259,479 |
| York Charles N II | COO, CFO and Secretary | 11/16/2022 | 9,228 |
| Blackman Samuel C. | Chief Medical Officer | 11/16/2022 | 8,090 |
| Bender Jeremy | Chief Executive Officer | 11/16/2022 | 32,469 |
| York Charles N II | COO, CFO and Secretary | 11/01/2022 | 200,313 |
| Grant Julie Papanek | Director | 11/01/2022 | 100,209 |
| Grant Julie Papanek | Director | 11/02/2022 | 100,069 |
| Blackman Samuel C. | Chief Medical Officer | 11/01/2022 | 200,050 |
| Bender Jeremy | Chief Executive Officer | 11/01/2022 | 250,355 |
| York Charles N II | COO, CFO and Secretary | 10/03/2022 | 200,473 |
| Grant Julie Papanek | Director | 10/04/2022 | 100,000 |
| Grant Julie Papanek | Director | 10/03/2022 | 100,315 |
| Blackman Samuel C. | Chief Medical Officer | 10/03/2022 | 199,852 |
| Bender Jeremy | Chief Executive Officer | 10/03/2022 | 250,646 |
| Canaan XI L.P. | 10% Owner | 09/21/2022 | 11,380,780 |
| Grant Julie Papanek | Director | 09/21/2022 | 11,380,780 |
| Grant Julie Papanek | Director | 09/20/2022 | 2,900,425 |
| Grant Julie Papanek | Director | 09/19/2022 | 1,578,233 |
| Grant Julie Papanek | Director | 09/16/2022 | 2,484,458 |
| Canaan XI L.P. | 10% Owner | 09/20/2022 | 2,900,425 |
| Canaan XI L.P. | 10% Owner | 09/19/2022 | 1,578,233 |
| Canaan XI L.P. | 10% Owner | 09/16/2022 | 2,484,458 |
| Grant Julie Papanek | Director | 09/15/2022 | 1,171,809 |
| Grant Julie Papanek | Director | 09/14/2022 | 2,512,943 |
| Grant Julie Papanek | Director | 09/13/2022 | 2,138,332 |
| Canaan XI L.P. | 10% Owner | 09/14/2022 | 2,512,943 |
| Canaan XI L.P. | 10% Owner | 09/13/2022 | 2,138,332 |
| Canaan XI L.P. | 10% Owner | 09/15/2022 | 1,171,809 |
| Grant Papanek Julie | Director | 09/02/2022 | 119,108 |
| York Charles N II | COO, CFO and Secretary | 09/01/2022 | 232,484 |
| Grant Papanek Julie | Director | 09/01/2022 | 116,358 |
| Blackman Samuel C. | Chief Medical Officer | 09/01/2022 | 232,452 |
| Bender Jeremy | Chief Executive Officer | 09/01/2022 | 290,581 |
| Bender Jeremy | Chief Executive Officer | 09/01/2022 | 290,581 |
| Blackman Samuel C. | Chief Medical Officer | 08/16/2022 | 22,876 |
| Bender Jeremy | Chief Executive Officer | 08/16/2022 | 97,313 |
| York Charles N II | COO, CFO and Secretary | 08/16/2022 | 26,474 |
| Grant Papanek Julie | Director | 08/05/2022 | 100,000 |
| Grant Papanek Julie | Director | 08/04/2022 | 100,004 |
| York Charles N II | COO, CFO and Secretary | 08/04/2022 | 200,541 |
| Bender Jeremy | Chief Executive Officer | 08/04/2022 | 250,021 |
| Blackman Samuel C. | Chief Medical Officer | 08/01/2022 | 168,810 |
| York Charles N II | COO, CFO and Secretary | 07/18/2022 | 50,000 |
| Grant Papanek Julie | Director | 07/18/2022 | 52,001 |
| Bender Jeremy | Chief Executive Officer | 07/18/2022 | 52,003 |
| Grant Papanek Julie | Director | 07/05/2022 | 16,000 |
| Grant Papanek Julie | Director | 07/01/2022 | 20,000 |
| Grant Papanek Julie | Director | 07/08/2022 | 24,840 |
| York Charles N II | COO, CFO and Secretary | 07/08/2022 | 28,320 |
| Bender Jeremy | Chief Executive Officer | 07/08/2022 | 35,900 |
| York Charles N II | COO, CFO and Secretary | 07/01/2022 | 29,580 |
| York Charles N II | COO, CFO and Secretary | 07/05/2022 | 16,000 |
| Grant Papanek Julie | Director | 07/05/2022 | 16,000 |
| Grant Papanek Julie | Director | 07/01/2022 | 20,000 |
| Blackman Samuel C. | Chief Medical Officer | 07/01/2022 | 187,158 |
| Bender Jeremy | Chief Executive Officer | 07/05/2022 | 17,140 |
| Bender Jeremy | Chief Executive Officer | 07/01/2022 | 34,920 |
| Atlas Venture Opportunity Fund II, L.P. | 10% Owner | 06/17/2022 | 11,500,005 |
| Gladstone Michael | Director | 06/17/2022 | 11,500,005 |
| AI Day1 LLC | 10% Owner | 06/17/2022 | 18,000,000 |
| Blackman Samuel C. | Chief Medical Officer | 06/15/2022 | 813,155 |
| AI Day1 LLC | 10% Owner | 01/20/2022 | 67,976 |
| AI Day1 LLC | 10% Owner | 01/19/2022 | 864,566 |
| AI Day1 LLC | 10% Owner | 01/18/2022 | 619,367 |
| Blackman Samuel C. | Chief Medical Officer | 01/03/2022 | 171,018 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 12/08/2021 | 1,989,394 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 12/07/2021 | 3,507,475 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 12/06/2021 | 1,763,341 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 12/03/2021 | 231,189 |
| Blackman Samuel C. | Chief Medical Officer | 12/01/2021 | 172,242 |
| Grant Papanek Julie | Director | 06/01/2021 | 208,000 |
| Josey John A. | Director | 06/01/2021 | 112,000 |
| Becker Daniel J. | Director | 06/01/2021 | 80,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN DAY ONE BIOPHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7,809,852 | 1.78% | No change | Other |
| BLACKROCK INC. | 5,126,071 | 0.00191% | 9.33% | Other |
| VIKING GLOBAL INVESTORS LP | 2,558,563 | 0.14% | No change | Growth At A Reasonable Price |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,761,178 | 0.47% | 38.68% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,348,819 | 0.00206% | 4.31% | Other |
| BAKER BROS. ADVISORS LP | 1,000,000 | 0.17% | No change | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 483,239 | 0.08% | -1.04% | Growth |
| CANDRIAM S.C.A. | 290,014 | 0.03% | No change | Other |
| D. E. SHAW & CO., INC. | 195,489 | 0.00249% | -0.38% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 150,000 | 0.00453% | -85.53% | Other |
| FISHER ASSET MANAGEMENT, LLC | 68,446 | 0.00053% | 89.04% | Other |
| ALPS ADVISORS INC | 59,695 | 0.00685% | -6.95% | Other |
| TUDOR INVESTMENT CORP ET AL | 33,367 | 0.00392% | New | Event Driven, Other |
| BALYASNY ASSET MANAGEMENT L.P. | 15,605 | 0.00043% | New | Event Driven |
| AQR CAPITAL MANAGEMENT LLC | 10,158 | 0.00028% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR DAY ONE BIOPHARMACEUTICALS INC
STOCK BUYBACKS FOR DAY ONE BIOPHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.11%
1Q
06/30/2023
14.78%
2Q
03/31/2023
19.55%
3Q
12/31/2022
20.68%
4Q
09/30/2022
21.18%
5Q
06/30/2022
41.61%
6Q
03/31/2022
47.38%
7Q
09/30/2021
49.61%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR DAY ONE BIOPHARMACEUTICALS INC
LOADING...